nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—ABCC10—Cytarabine—lymphatic system cancer	0.28	0.355	CbGbCtD
Vincristine—ABCC10—Methotrexate—lymphatic system cancer	0.0804	0.102	CbGbCtD
Vincristine—ABCC1—Mitoxantrone—lymphatic system cancer	0.0745	0.0945	CbGbCtD
Vincristine—ABCG2—Teniposide—lymphatic system cancer	0.0713	0.0904	CbGbCtD
Vincristine—ABCC3—Methotrexate—lymphatic system cancer	0.0505	0.0642	CbGbCtD
Vincristine—ABCG2—Mitoxantrone—lymphatic system cancer	0.0498	0.0633	CbGbCtD
Vincristine—CYP3A5—Teniposide—lymphatic system cancer	0.0395	0.0501	CbGbCtD
Vincristine—ABCC1—Methotrexate—lymphatic system cancer	0.031	0.0394	CbGbCtD
Vincristine—ABCC2—Methotrexate—lymphatic system cancer	0.023	0.0292	CbGbCtD
Vincristine—ABCG2—Methotrexate—lymphatic system cancer	0.0208	0.0264	CbGbCtD
Vincristine—ABCB1—Mitoxantrone—lymphatic system cancer	0.018	0.0228	CbGbCtD
Vincristine—CYP3A4—Cytarabine—lymphatic system cancer	0.0156	0.0198	CbGbCtD
Vincristine—CYP3A4—Teniposide—lymphatic system cancer	0.0154	0.0195	CbGbCtD
Vincristine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0108	0.0137	CbGbCtD
Vincristine—ABCB1—Methotrexate—lymphatic system cancer	0.00749	0.0095	CbGbCtD
Vincristine—TUBB6—Zalcitabine—Cytarabine—lymphatic system cancer	0.00193	0.403	CbGdCrCtD
Vincristine—TUBB—Azacitidine—Fludarabine—lymphatic system cancer	0.00104	0.217	CbGdCrCtD
Vincristine—TUBB—Azacitidine—Cytarabine—lymphatic system cancer	0.000983	0.205	CbGdCrCtD
Vincristine—Dysuria—Fludarabine—lymphatic system cancer	0.000821	0.00396	CcSEcCtD
Vincristine—Neutropenia—Fludarabine—lymphatic system cancer	0.000821	0.00396	CcSEcCtD
Vincristine—Coma—Carmustine—lymphatic system cancer	0.000819	0.00395	CcSEcCtD
Vincristine—Pneumonia—Fludarabine—lymphatic system cancer	0.000788	0.0038	CcSEcCtD
Vincristine—Azotaemia—Methotrexate—lymphatic system cancer	0.000779	0.00376	CcSEcCtD
Vincristine—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.000772	0.00373	CcSEcCtD
Vincristine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.000771	0.00372	CcSEcCtD
Vincristine—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.000768	0.0037	CcSEcCtD
Vincristine—Myocardial infarction—Fludarabine—lymphatic system cancer	0.000768	0.0037	CcSEcCtD
Vincristine—Infection—Mechlorethamine—lymphatic system cancer	0.000766	0.0037	CcSEcCtD
Vincristine—Stomatitis—Fludarabine—lymphatic system cancer	0.000764	0.00368	CcSEcCtD
Vincristine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.000755	0.00364	CcSEcCtD
Vincristine—Anorexia—Mechlorethamine—lymphatic system cancer	0.000735	0.00355	CcSEcCtD
Vincristine—Alopecia—Teniposide—lymphatic system cancer	0.000707	0.00341	CcSEcCtD
Vincristine—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.0007	0.00338	CcSEcCtD
Vincristine—Febrile neutropenia—Methotrexate—lymphatic system cancer	0.00069	0.00333	CcSEcCtD
Vincristine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00067	0.00323	CcSEcCtD
Vincristine—Hyponatraemia—Carmustine—lymphatic system cancer	0.000653	0.00315	CcSEcCtD
Vincristine—Anaemia—Teniposide—lymphatic system cancer	0.000644	0.00311	CcSEcCtD
Vincristine—Agitation—Teniposide—lymphatic system cancer	0.00064	0.00309	CcSEcCtD
Vincristine—Leukopenia—Teniposide—lymphatic system cancer	0.000623	0.00301	CcSEcCtD
Vincristine—Alopecia—Fludarabine—lymphatic system cancer	0.000621	0.003	CcSEcCtD
Vincristine—Bone marrow depression—Methotrexate—lymphatic system cancer	0.000615	0.00297	CcSEcCtD
Vincristine—Pancytopenia—Bleomycin—lymphatic system cancer	0.000612	0.00295	CcSEcCtD
Vincristine—Ataxia—Carmustine—lymphatic system cancer	0.000612	0.00295	CcSEcCtD
Vincristine—Hyponatraemia—Mitoxantrone—lymphatic system cancer	0.000607	0.00293	CcSEcCtD
Vincristine—Hypertension—Teniposide—lymphatic system cancer	0.000601	0.0029	CcSEcCtD
Vincristine—Paralysis—Methotrexate—lymphatic system cancer	0.000597	0.00288	CcSEcCtD
Vincristine—Weight decreased—Bleomycin—lymphatic system cancer	0.000583	0.00281	CcSEcCtD
Vincristine—Pneumonia—Bleomycin—lymphatic system cancer	0.000578	0.00279	CcSEcCtD
Vincristine—Muscular weakness—Carmustine—lymphatic system cancer	0.000574	0.00277	CcSEcCtD
Vincristine—Oedema—Teniposide—lymphatic system cancer	0.000568	0.00274	CcSEcCtD
Vincristine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.000568	0.00274	CcSEcCtD
Vincristine—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.000566	0.00273	CcSEcCtD
Vincristine—Anaemia—Fludarabine—lymphatic system cancer	0.000566	0.00273	CcSEcCtD
Vincristine—Infection—Teniposide—lymphatic system cancer	0.000565	0.00272	CcSEcCtD
Vincristine—Myocardial infarction—Bleomycin—lymphatic system cancer	0.000563	0.00272	CcSEcCtD
Vincristine—Agitation—Fludarabine—lymphatic system cancer	0.000563	0.00271	CcSEcCtD
Vincristine—Dehydration—Mitoxantrone—lymphatic system cancer	0.000562	0.00271	CcSEcCtD
Vincristine—Stomatitis—Bleomycin—lymphatic system cancer	0.00056	0.0027	CcSEcCtD
Vincristine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.000557	0.00269	CcSEcCtD
Vincristine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00055	0.00265	CcSEcCtD
Vincristine—Leukopenia—Fludarabine—lymphatic system cancer	0.000548	0.00264	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.000545	0.00263	CcSEcCtD
Vincristine—Anorexia—Teniposide—lymphatic system cancer	0.000542	0.00261	CcSEcCtD
Vincristine—Pancytopenia—Carmustine—lymphatic system cancer	0.000534	0.00258	CcSEcCtD
Vincristine—Hypotension—Teniposide—lymphatic system cancer	0.000531	0.00256	CcSEcCtD
Vincristine—Convulsion—Fludarabine—lymphatic system cancer	0.00053	0.00256	CcSEcCtD
Vincristine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000528	0.00255	CcSEcCtD
Vincristine—Neutropenia—Carmustine—lymphatic system cancer	0.000526	0.00254	CcSEcCtD
Vincristine—Myalgia—Fludarabine—lymphatic system cancer	0.000521	0.00251	CcSEcCtD
Vincristine—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.000513	0.00247	CcSEcCtD
Vincristine—Pneumonia—Carmustine—lymphatic system cancer	0.000504	0.00243	CcSEcCtD
Vincristine—Depression—Carmustine—lymphatic system cancer	0.0005	0.00241	CcSEcCtD
Vincristine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0005	0.00241	CcSEcCtD
Vincristine—Oedema—Fludarabine—lymphatic system cancer	0.0005	0.00241	CcSEcCtD
Vincristine—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.000496	0.00239	CcSEcCtD
Vincristine—Infection—Fludarabine—lymphatic system cancer	0.000496	0.00239	CcSEcCtD
Vincristine—Decreased appetite—Teniposide—lymphatic system cancer	0.000494	0.00238	CcSEcCtD
Vincristine—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.000491	0.00237	CcSEcCtD
Vincristine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00049	0.00237	CcSEcCtD
Vincristine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00049	0.00236	CcSEcCtD
Vincristine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000489	0.00236	CcSEcCtD
Vincristine—Neutropenia—Mitoxantrone—lymphatic system cancer	0.000489	0.00236	CcSEcCtD
Vincristine—Stomatitis—Carmustine—lymphatic system cancer	0.000489	0.00236	CcSEcCtD
Vincristine—Rash—Mechlorethamine—lymphatic system cancer	0.000486	0.00235	CcSEcCtD
Vincristine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000486	0.00234	CcSEcCtD
Vincristine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000483	0.00233	CcSEcCtD
Vincristine—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.000481	0.00232	CcSEcCtD
Vincristine—Anorexia—Fludarabine—lymphatic system cancer	0.000476	0.0023	CcSEcCtD
Vincristine—Extravasation—Methotrexate—lymphatic system cancer	0.000476	0.0023	CcSEcCtD
Vincristine—Weight decreased—Mitoxantrone—lymphatic system cancer	0.000473	0.00228	CcSEcCtD
Vincristine—Pneumonia—Mitoxantrone—lymphatic system cancer	0.000469	0.00226	CcSEcCtD
Vincristine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000465	0.00224	CcSEcCtD
Vincristine—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.000459	0.00222	CcSEcCtD
Vincristine—Nausea—Mechlorethamine—lymphatic system cancer	0.000458	0.00221	CcSEcCtD
Vincristine—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.000457	0.0022	CcSEcCtD
Vincristine—Alopecia—Bleomycin—lymphatic system cancer	0.000456	0.0022	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000455	0.0022	CcSEcCtD
Vincristine—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000454	0.00219	CcSEcCtD
Vincristine—Abdominal pain—Teniposide—lymphatic system cancer	0.000449	0.00217	CcSEcCtD
Vincristine—Body temperature increased—Teniposide—lymphatic system cancer	0.000449	0.00217	CcSEcCtD
Vincristine—Paraesthesia—Fludarabine—lymphatic system cancer	0.000449	0.00216	CcSEcCtD
Vincristine—Hallucination—Carmustine—lymphatic system cancer	0.000448	0.00216	CcSEcCtD
Vincristine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.000448	0.00216	CcSEcCtD
Vincristine—Hyperuricaemia—Methotrexate—lymphatic system cancer	0.000447	0.00216	CcSEcCtD
Vincristine—Sweating—Mitoxantrone—lymphatic system cancer	0.000447	0.00216	CcSEcCtD
Vincristine—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000442	0.00213	CcSEcCtD
Vincristine—Decreased appetite—Fludarabine—lymphatic system cancer	0.000434	0.0021	CcSEcCtD
Vincristine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000431	0.00208	CcSEcCtD
Vincristine—Fatigue—Fludarabine—lymphatic system cancer	0.000431	0.00208	CcSEcCtD
Vincristine—TUBB6—Azacitidine—Fludarabine—lymphatic system cancer	0.00043	0.0898	CbGdCrCtD
Vincristine—Pain—Fludarabine—lymphatic system cancer	0.000427	0.00206	CcSEcCtD
Vincristine—Constipation—Fludarabine—lymphatic system cancer	0.000427	0.00206	CcSEcCtD
Vincristine—Respiratory failure—Methotrexate—lymphatic system cancer	0.000423	0.00204	CcSEcCtD
Vincristine—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.000423	0.00204	CcSEcCtD
Vincristine—Hypersensitivity—Teniposide—lymphatic system cancer	0.000419	0.00202	CcSEcCtD
Vincristine—Anaemia—Bleomycin—lymphatic system cancer	0.000415	0.002	CcSEcCtD
Vincristine—Asthenia—Teniposide—lymphatic system cancer	0.000408	0.00197	CcSEcCtD
Vincristine—TUBB6—Azacitidine—Cytarabine—lymphatic system cancer	0.000406	0.0848	CbGdCrCtD
Vincristine—Leukopenia—Bleomycin—lymphatic system cancer	0.000402	0.00194	CcSEcCtD
Vincristine—Alopecia—Carmustine—lymphatic system cancer	0.000398	0.00192	CcSEcCtD
Vincristine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000395	0.00191	CcSEcCtD
Vincristine—Mental disorder—Carmustine—lymphatic system cancer	0.000394	0.0019	CcSEcCtD
Vincristine—Diarrhoea—Teniposide—lymphatic system cancer	0.000389	0.00188	CcSEcCtD
Vincristine—Myalgia—Bleomycin—lymphatic system cancer	0.000382	0.00184	CcSEcCtD
Vincristine—Coma—Methotrexate—lymphatic system cancer	0.000379	0.00183	CcSEcCtD
Vincristine—Back pain—Carmustine—lymphatic system cancer	0.000379	0.00183	CcSEcCtD
Vincristine—Urine output increased—Methotrexate—lymphatic system cancer	0.000375	0.00181	CcSEcCtD
Vincristine—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000375	0.00181	CcSEcCtD
Vincristine—Alopecia—Mitoxantrone—lymphatic system cancer	0.00037	0.00178	CcSEcCtD
Vincristine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000368	0.00178	CcSEcCtD
Vincristine—Oedema—Bleomycin—lymphatic system cancer	0.000366	0.00177	CcSEcCtD
Vincristine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000366	0.00177	CcSEcCtD
Vincristine—Infection—Bleomycin—lymphatic system cancer	0.000364	0.00176	CcSEcCtD
Vincristine—Anaemia—Carmustine—lymphatic system cancer	0.000362	0.00175	CcSEcCtD
Vincristine—Vomiting—Teniposide—lymphatic system cancer	0.000361	0.00174	CcSEcCtD
Vincristine—Agitation—Carmustine—lymphatic system cancer	0.00036	0.00174	CcSEcCtD
Vincristine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000359	0.00173	CcSEcCtD
Vincristine—Asthenia—Fludarabine—lymphatic system cancer	0.000358	0.00173	CcSEcCtD
Vincristine—Rash—Teniposide—lymphatic system cancer	0.000358	0.00173	CcSEcCtD
Vincristine—Dermatitis—Teniposide—lymphatic system cancer	0.000358	0.00173	CcSEcCtD
Vincristine—Headache—Teniposide—lymphatic system cancer	0.000356	0.00172	CcSEcCtD
Vincristine—Back pain—Mitoxantrone—lymphatic system cancer	0.000352	0.0017	CcSEcCtD
Vincristine—Leukopenia—Carmustine—lymphatic system cancer	0.000351	0.00169	CcSEcCtD
Vincristine—Anorexia—Bleomycin—lymphatic system cancer	0.000349	0.00168	CcSEcCtD
Vincristine—Polyuria—Methotrexate—lymphatic system cancer	0.000343	0.00166	CcSEcCtD
Vincristine—Hypotension—Bleomycin—lymphatic system cancer	0.000342	0.00165	CcSEcCtD
Vincristine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000342	0.00165	CcSEcCtD
Vincristine—Convulsion—Carmustine—lymphatic system cancer	0.000339	0.00164	CcSEcCtD
Vincristine—Hypertension—Carmustine—lymphatic system cancer	0.000338	0.00163	CcSEcCtD
Vincristine—Nausea—Teniposide—lymphatic system cancer	0.000338	0.00163	CcSEcCtD
Vincristine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000337	0.00162	CcSEcCtD
Vincristine—Hepatic failure—Methotrexate—lymphatic system cancer	0.000335	0.00162	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000334	0.00161	CcSEcCtD
Vincristine—Myalgia—Carmustine—lymphatic system cancer	0.000334	0.00161	CcSEcCtD
Vincristine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000329	0.00159	CcSEcCtD
Vincristine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000326	0.00157	CcSEcCtD
Vincristine—Oedema—Carmustine—lymphatic system cancer	0.00032	0.00154	CcSEcCtD
Vincristine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000318	0.00154	CcSEcCtD
Vincristine—Infection—Carmustine—lymphatic system cancer	0.000318	0.00153	CcSEcCtD
Vincristine—Vomiting—Fludarabine—lymphatic system cancer	0.000318	0.00153	CcSEcCtD
Vincristine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000316	0.00152	CcSEcCtD
Vincristine—Rash—Fludarabine—lymphatic system cancer	0.000315	0.00152	CcSEcCtD
Vincristine—Dermatitis—Fludarabine—lymphatic system cancer	0.000315	0.00152	CcSEcCtD
Vincristine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000314	0.00152	CcSEcCtD
Vincristine—Pain—Bleomycin—lymphatic system cancer	0.000313	0.00151	CcSEcCtD
Vincristine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000313	0.00151	CcSEcCtD
Vincristine—Headache—Fludarabine—lymphatic system cancer	0.000313	0.00151	CcSEcCtD
Vincristine—Myalgia—Mitoxantrone—lymphatic system cancer	0.00031	0.0015	CcSEcCtD
Vincristine—Anorexia—Carmustine—lymphatic system cancer	0.000305	0.00147	CcSEcCtD
Vincristine—Hypotension—Carmustine—lymphatic system cancer	0.000299	0.00144	CcSEcCtD
Vincristine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000297	0.00143	CcSEcCtD
Vincristine—Oedema—Mitoxantrone—lymphatic system cancer	0.000297	0.00143	CcSEcCtD
Vincristine—Nausea—Fludarabine—lymphatic system cancer	0.000297	0.00143	CcSEcCtD
Vincristine—Infection—Mitoxantrone—lymphatic system cancer	0.000295	0.00142	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000291	0.00141	CcSEcCtD
Vincristine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000291	0.0014	CcSEcCtD
Vincristine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00029	0.0014	CcSEcCtD
Vincristine—Insomnia—Carmustine—lymphatic system cancer	0.000289	0.0014	CcSEcCtD
Vincristine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000287	0.00139	CcSEcCtD
Vincristine—Paraesthesia—Carmustine—lymphatic system cancer	0.000287	0.00139	CcSEcCtD
Vincristine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000283	0.00137	CcSEcCtD
Vincristine—Ataxia—Methotrexate—lymphatic system cancer	0.000283	0.00137	CcSEcCtD
Vincristine—Decreased appetite—Carmustine—lymphatic system cancer	0.000278	0.00134	CcSEcCtD
Vincristine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000278	0.00134	CcSEcCtD
Vincristine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000276	0.00133	CcSEcCtD
Vincristine—Pain—Carmustine—lymphatic system cancer	0.000273	0.00132	CcSEcCtD
Vincristine—Constipation—Carmustine—lymphatic system cancer	0.000273	0.00132	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000271	0.00131	CcSEcCtD
Vincristine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00027	0.0013	CcSEcCtD
Vincristine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000267	0.00129	CcSEcCtD
Vincristine—Asthenia—Bleomycin—lymphatic system cancer	0.000263	0.00127	CcSEcCtD
Vincristine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000261	0.00126	CcSEcCtD
Vincristine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000258	0.00125	CcSEcCtD
Vincristine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000256	0.00124	CcSEcCtD
Vincristine—Constipation—Mitoxantrone—lymphatic system cancer	0.000254	0.00123	CcSEcCtD
Vincristine—Pain—Mitoxantrone—lymphatic system cancer	0.000254	0.00123	CcSEcCtD
Vincristine—Abdominal pain—Carmustine—lymphatic system cancer	0.000253	0.00122	CcSEcCtD
Vincristine—Body temperature increased—Carmustine—lymphatic system cancer	0.000253	0.00122	CcSEcCtD
Vincristine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000247	0.00119	CcSEcCtD
Vincristine—Neutropenia—Methotrexate—lymphatic system cancer	0.000244	0.00117	CcSEcCtD
Vincristine—Dysuria—Methotrexate—lymphatic system cancer	0.000244	0.00117	CcSEcCtD
Vincristine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000243	0.00117	CcSEcCtD
Vincristine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00024	0.00116	CcSEcCtD
Vincristine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000238	0.00115	CcSEcCtD
Vincristine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000236	0.00114	CcSEcCtD
Vincristine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000235	0.00113	CcSEcCtD
Vincristine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000235	0.00113	CcSEcCtD
Vincristine—Pneumonia—Methotrexate—lymphatic system cancer	0.000234	0.00113	CcSEcCtD
Vincristine—Vomiting—Bleomycin—lymphatic system cancer	0.000233	0.00112	CcSEcCtD
Vincristine—Depression—Methotrexate—lymphatic system cancer	0.000232	0.00112	CcSEcCtD
Vincristine—Rash—Bleomycin—lymphatic system cancer	0.000231	0.00111	CcSEcCtD
Vincristine—Dermatitis—Bleomycin—lymphatic system cancer	0.000231	0.00111	CcSEcCtD
Vincristine—Asthenia—Carmustine—lymphatic system cancer	0.000229	0.00111	CcSEcCtD
Vincristine—Stomatitis—Methotrexate—lymphatic system cancer	0.000226	0.00109	CcSEcCtD
Vincristine—Sweating—Methotrexate—lymphatic system cancer	0.000223	0.00107	CcSEcCtD
Vincristine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000219	0.00106	CcSEcCtD
Vincristine—Diarrhoea—Carmustine—lymphatic system cancer	0.000219	0.00106	CcSEcCtD
Vincristine—Nausea—Bleomycin—lymphatic system cancer	0.000218	0.00105	CcSEcCtD
Vincristine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000213	0.00103	CcSEcCtD
Vincristine—Dizziness—Carmustine—lymphatic system cancer	0.000211	0.00102	CcSEcCtD
Vincristine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000206	0.000993	CcSEcCtD
Vincristine—Urethral disorder—Methotrexate—lymphatic system cancer	0.000204	0.000986	CcSEcCtD
Vincristine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000203	0.000981	CcSEcCtD
Vincristine—Vomiting—Carmustine—lymphatic system cancer	0.000203	0.000981	CcSEcCtD
Vincristine—Rash—Carmustine—lymphatic system cancer	0.000202	0.000973	CcSEcCtD
Vincristine—Dermatitis—Carmustine—lymphatic system cancer	0.000201	0.000972	CcSEcCtD
Vincristine—Headache—Carmustine—lymphatic system cancer	0.0002	0.000966	CcSEcCtD
Vincristine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000193	0.000933	CcSEcCtD
Vincristine—Nausea—Carmustine—lymphatic system cancer	0.00019	0.000916	CcSEcCtD
Vincristine—Angiopathy—Methotrexate—lymphatic system cancer	0.000189	0.000912	CcSEcCtD
Vincristine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000189	0.000912	CcSEcCtD
Vincristine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000188	0.000906	CcSEcCtD
Vincristine—Rash—Mitoxantrone—lymphatic system cancer	0.000187	0.000904	CcSEcCtD
Vincristine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000187	0.000903	CcSEcCtD
Vincristine—Headache—Mitoxantrone—lymphatic system cancer	0.000186	0.000898	CcSEcCtD
Vincristine—Alopecia—Methotrexate—lymphatic system cancer	0.000184	0.000889	CcSEcCtD
Vincristine—Mental disorder—Methotrexate—lymphatic system cancer	0.000183	0.000881	CcSEcCtD
Vincristine—Nausea—Mitoxantrone—lymphatic system cancer	0.000177	0.000852	CcSEcCtD
Vincristine—Back pain—Methotrexate—lymphatic system cancer	0.000176	0.000847	CcSEcCtD
Vincristine—Anaemia—Methotrexate—lymphatic system cancer	0.000168	0.000809	CcSEcCtD
Vincristine—Vertigo—Methotrexate—lymphatic system cancer	0.000163	0.000787	CcSEcCtD
Vincristine—Leukopenia—Methotrexate—lymphatic system cancer	0.000162	0.000784	CcSEcCtD
Vincristine—Convulsion—Methotrexate—lymphatic system cancer	0.000157	0.000759	CcSEcCtD
Vincristine—Myalgia—Methotrexate—lymphatic system cancer	0.000154	0.000745	CcSEcCtD
Vincristine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000148	0.000715	CcSEcCtD
Vincristine—Infection—Methotrexate—lymphatic system cancer	0.000147	0.00071	CcSEcCtD
Vincristine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000145	0.000701	CcSEcCtD
Vincristine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000145	0.0007	CcSEcCtD
Vincristine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000143	0.000691	CcSEcCtD
Vincristine—Anorexia—Methotrexate—lymphatic system cancer	0.000141	0.000681	CcSEcCtD
Vincristine—Hypotension—Methotrexate—lymphatic system cancer	0.000138	0.000668	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000135	0.000651	CcSEcCtD
Vincristine—Insomnia—Methotrexate—lymphatic system cancer	0.000134	0.000646	CcSEcCtD
Vincristine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000133	0.000642	CcSEcCtD
Vincristine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000129	0.000621	CcSEcCtD
Vincristine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000128	0.000617	CcSEcCtD
Vincristine—Fatigue—Methotrexate—lymphatic system cancer	0.000128	0.000616	CcSEcCtD
Vincristine—Pain—Methotrexate—lymphatic system cancer	0.000127	0.000611	CcSEcCtD
Vincristine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000121	0.000584	CcSEcCtD
Vincristine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000117	0.000565	CcSEcCtD
Vincristine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000117	0.000565	CcSEcCtD
Vincristine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000109	0.000526	CcSEcCtD
Vincristine—Asthenia—Methotrexate—lymphatic system cancer	0.000106	0.000513	CcSEcCtD
Vincristine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000101	0.000489	CcSEcCtD
Vincristine—Dizziness—Methotrexate—lymphatic system cancer	9.79e-05	0.000472	CcSEcCtD
Vincristine—Vomiting—Methotrexate—lymphatic system cancer	9.42e-05	0.000454	CcSEcCtD
Vincristine—Rash—Methotrexate—lymphatic system cancer	9.34e-05	0.000451	CcSEcCtD
Vincristine—Dermatitis—Methotrexate—lymphatic system cancer	9.33e-05	0.00045	CcSEcCtD
Vincristine—Headache—Methotrexate—lymphatic system cancer	9.28e-05	0.000448	CcSEcCtD
Vincristine—Nausea—Methotrexate—lymphatic system cancer	8.8e-05	0.000424	CcSEcCtD
